Table 1.
Demographics and clinical features in both groups
| Parameter | Control group | BCL group | P Value |
|---|---|---|---|
| Number of eyes | 70 | 70 | |
| OD (%) | 37 (52.86%) | 33 (47.14%) | 0.306 |
| Female (%) | 32 (52.5%) | 30 (50.8%) | 0.502 |
| Age (range) | 75.67 ± 7.50 (61–94) | 75.07 ± 7.82 (60–91) | 0.674 |
| NIKTMH (mm) | 0.18 ± 0.08 | 0.18 ± 0.08 | 0.511 |
| NIF-BUT (s) | 4.37 ± 2.54 | 4.18 ± 2.33 | 0.654 |
| NIAvg-BUT (s) | 5.35 ± 3.04 | 5.07 ± 2.73 | 0.571 |
| Redness score (0–4) | 2.07 ± 0.46 | 2.03 ± 0.48 | 0.591 |
| Meibography score (0–6) | 3.59 ± 1.42 | 3.67 ± 1.43 | 0.729 |
| Schirmer I test (mm) | 7.11 ± 2.95 | 8.05 ± 4.67 | 0.175 |
| OSDI (0–100) | 20.35 ± 19.31 | 22.78 ± 23.04 | 0.511 |
NIKTMH noninvasive keratograph tear meniscus height; NIF-BUT noninvasive first breakup time; NIAvg-BUT noninvasive average breakup time; OSDI Ocular Surface Disease Index. Data are presented as means ± standard deviation (SD)